翔宇医疗: management transactions · France · AMF SSE:688626 FR FR · AMF Mcap 9.7Bn€
Browse the full directors' dealings record of 翔宇医疗, a listed issuer based in France. Shares are listed on FR FR, under the supervision of AMF. Market capitalisation: €9.7bn. The latest transaction was disclosed on 1 June 2022 — Purchase. Among the most active insiders: 何永正. Every trade is accessible without an account.
Financial data FY ended December 2025 · cache
Income statement
Revenue 767.7 M€
Gross profit 511.5 M€ 67% margin
Net income 78.2 M€ 10.2% margin
Balance sheet & cash
Market cap 9.68 Bn€
Total debt 574.2 M€
Free Cash Flow −97.4 M€
Last declaration on 1 June 2022
Declarations 8 total
Executives ● Purchase7 SSE
6,000 shares
SSE:173000005560699800 · 1 Jun 2022
Ideal exit: 26 Feb 2023 (T+270) Executives ● Purchase7 SSE
52,056 shares
SSE:173000005552153200 · 27 May 2022
Ideal exit: 21 Feb 2023 (T+270) Executives ● Purchase7 SSE
21,674 shares
SSE:173000005539458980 · 20 May 2022
Ideal exit: 14 Feb 2023 (T+270) Executives ● Purchase7 SSE
18,000 shares
SSE:173000005537107330 · 19 May 2022
Ideal exit: 13 Feb 2023 (T+270) Executives ● Purchase7 SSE
5,000 shares
SSE:173000005533907260 · 18 May 2022
Ideal exit: 12 Feb 2023 (T+270) Executives ● Purchase10 SSE
15,000 shares
SSE:173000005520472450 · 12 May 2022
Ideal exit: 6 Feb 2023 (T+270) Executives ● Purchase7 SSE
121,374 shares
SSE:173000005516541340 · 11 May 2022
Ideal exit: 5 Feb 2023 (T+270) Executives ● Purchase7 SSE
100,500 shares
SSE:173000005514216930 · 10 May 2022
Ideal exit: 4 Feb 2023 (T+270)